Press releases and news

2021-09-17 11:15
NEWS: Uppsala September 17, 2021. In the October 2021 edition of Anesthesiology, the Official Journal of the American Society of Anesthesiology, a comparative study of the Senzime TetraGraph EMG monitor and the previous gold-standard TOF-Watch AMG monitor...

2021-09-13 16:35
NEWS: Uppsala September 13 2021. Recently published studies with an EMG monitor shows that the purchase can result in a robust cost benefit despite the expense associated with the technology, by reducing the risk of postoperative residual neuromuscular...

2021-08-27 08:45 Regulatory Interim
Press release: Uppsala, August 27, 2021. Senzime AB’s (publ) Interim Report for January-June 2021 is now available on the company’s website www.senzime.com. Financial information for April - June 2021 Financial information for January - June...

2021-06-30 07:00 Regulatory
Uppsala, 30 June 2021. Senzime AB (publ) announces that the company’s shares are admitted for trading on Nasdaq Stockholm's main market today. “It’s fantastic milestone for Senzime to be listed on Nasdaq Stockholm's main market. Senzime...

2021-06-24 11:05 Regulatory
Uppsala, 24 June 2021. On 23 June 2021, Senzime AB (publ) announced that Nasdaq Stockholm’s Listing Committee had approved that the company’s shares are admitted to trading on Nasdaq Stockholm’s main market, conditioned upon customary...

2021-06-23 15:30 Regulatory
Uppsala, 23 June 2021. Senzime AB (publ) announces that Nasdaq Stockholm's Listing Committee has approved the company’s application for admission of trading of the company’s shares on Nasdaq Stockholm’s main market. The approval is conditioned...

2021-06-17 12:15
News: Uppsala, on 17 June 2021. Senzimes distributor comments on the field development following the new guidelines. In recent communications information on the new launch of the AAGBI guidelines were referenced. These guidelines state that in the UK...

2021-05-22 20:30
News: Uppsala, on 22 May 2021. Senzime today announces that the Association of Anaesthetists in the UK and Ireland has issued new standards for neuromuscular monitoring stating that Quantitative neuromuscular monitoring is essential and should be available...

2021-05-11 14:25 Regulatory
The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) was held on 11 May 2021 by postal voting whereby the shareholders primarily resolved on the following matters. Annual report and results The annual...

2021-05-06 08:45 Regulatory Interim
Press release: Uppsala, May 6, 2021. Senzime AB’s (publ) Interim Report for January-March 2021 is now available on the company’s website www.senzime.com. Financial information January – March Despite the fact that Covid-19 continued...